Roswell Park Cancer Institute (RPCI) has considerable expertise in the development and conduct of pilot, phase I and phase I/I I studies, which are the foundation for the development of novel therapeutic approaches in hematologic and solid tumor malignancies. The Protocol-Specific Research Support (PSRS) Resource supports the conduct of innovative pilot, phase I and phase l/ll clinical investigations developed by RPCI investigators and emanating from the CCSG Programs. The continued vitality and translational potential of CCSG Programs relies critically on this support for early phase studies. With the recent recruitment of a number of new investigators to the CCSG Programs and RPCI, it is anticipated that accrual will increase substantially over the next several years. Alex A. Adjei, MD, PhD has been recruited to RPCI and now serves as director of this Resource. The primary responsibilities of the clinical research coordinators in this Resource are the implementation, conduct, oversight, collection and quality control of data for phase I and pilot studies. Dr. Adjei oversees the prioritization for the use of PSRS resources in his capacity as Associate Director for Clinical Research and Director of Clinical Shared Resources. In order to be eligible for PSRS, the study must be led by an RPCI investigator or have resulted from clinical or preclinical studies performed by an RPCI investigator with an RPCI faculty member as a co-investigator. Over the last grant period, a number of studies have been activated based on basic research findings of CCSG investigators in vitamin D, selenium and the NY-ESO-1 antigen, among others. Examples include a pilot study of low and high dose vitamin D3 with pharmacokinetic and pharmacodynamic correlates in resected colon cancer (Fakih, Trump and Johnson), calcitriol combined with gefitinib, selenomethionine and irinotecan (Fakih) and NY-ESO-1 antigen vaccination for ovarian cancer (Odunsi). A new photosensitizer for photodynamic therapy, HPPH has been tested in a phase I study (Henderson). Future development continues. A study of surgery combined with intra-operative photodynamic therapy in head and neck cancers is ongoing (Rigual). Other studies include a pilot study of the effect of low glycemic index diet on breast density (McCann), Hsp-based vaccines (Subjeck, Kane, Yang), and novel diagnostic/prognostic marker evaluations - FRA12/SMRT (Coignet, Trump). All these projects were developed with, have led to, or are future components of peer-reviewed funding support.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Roswell Park Cancer Institute Corp
United States
Zip Code
Rossetti, Stefano; Wierzbicki, Andrzej J; Sacchi, Nicoletta (2018) Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer. Oncotarget 9:5016-5031
Block, Matthew S; Vierkant, Robert A; Rambau, Peter F et al. (2018) MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 93:307-320
Li, Qiuhui; Deng, Qu; Chao, Hsueh-Ping et al. (2018) Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9:3600
Kawaguchi, Tstutomu; Yan, Li; Qi, Qianya et al. (2018) Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol 25:4037-4046
Mett, V; Komarova, E A; Greene, K et al. (2018) Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene 37:439-449
Long, Mark D; Singh, Prashant K; Russell, James R et al. (2018) The miR-96 and RAR? signaling axis governs androgen signaling and prostate cancer progression. Oncogene :
Hirose, Yuki; Nagahashi, Masayuki; Katsuta, Eriko et al. (2018) Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis. Sci Rep 8:10814
Vexler, Albert; Yu, Jihnhee; Zhao, Yang et al. (2018) Expected p-values in light of an ROC curve analysis applied to optimal multiple testing procedures. Stat Methods Med Res 27:3560-3576
Mussell, Ashley L; Denson, Kayla E; Shen, He et al. (2018) Loss of KIBRA function activates EGFR signaling by inducing AREG. Oncotarget 9:29975-29984
Yendamuri, Sai; Groman, Adrienne; Miller, Austin et al. (2018) Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. Eur J Cardiothorac Surg 53:656-663

Showing the most recent 10 out of 1555 publications